AdvaMed® Comments on OSTP Request for Information: Regulatory Reform on Artificial Intelligence
AdvaMed® Comments on OSTP Request for Information: Regulatory Reform on Artificial Intelligence
Government & Legislative Affairs
Learn more about our Advocacy work.
AdvaMed® Statement on Commerce Department Section 232 National Security Investigation
WASHINGTON—AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker on the Administration’s announcement of its investigation under Section 232 of the Trade Expansion Act into…
AdvaMed® Thanks U.S. House Energy and Commerce Health Subcommittee for Highlighting the Need for Medicare Coverage of Breakthrough Medtech
WASHINGTON—AdvaMed, the MedTech Association®, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft…
AdvaMed® Welcomes Key U.S. House Committee Passage of Breakthrough Medtech Coverage Bill, Urges Addition of Diagnostic Tests
WASHINGTON—AdvaMed, the MedTech Association®, today welcomed U.S. House of Representatives Committee on Ways and Means passage of legislation providing Medicare coverage of FDA-designated and authorized breakthrough medtech.AdvaMed® also urged legislators…
AdvaMed® Welcomes CMS’ Rural Health Transformation Program
WASHINGTON—AdvaMed, the MedTech Association®, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health…
AdvaMed® Welcomes Bipartisan Bill to Support Patient Access to Laboratory Testing
WASHINGTON—AdvaMed, the MedTech Association®, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act…
AdvaMed® in Action: Building Alliances That Redefine Health Care at The MedTech Conference 2025
Bobby Patrick, AdvaMed’s SVP of Government & State Affairs and Alliance Development, on why #MTC25 is the can’t-miss moment to see the power of coalitions in action — where patients,…
CDRH Director Tarver, Fellow FDA Leaders to Speak, Take Questions at The MedTech Conference
WASHINGTON, D.C.—AdvaMed, the MedTech Association®, today announced a town hall featuring FDA Center for Devices and Radiological Health (CDRH) Director Michelle Tarver and fellow CDRH senior leaders at The MedTech…
AdvaMed® Urges CMS to Fix “Serious Flaws” in Proposed Medicare Durable Medical Equipment Competitive Bidding Rule, Cites Concerns of Patient Safety, Fewer Treatment Options, Increased Costs if Rule Stands
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart…
Smart Back-to-School Policy: Cell Phone Bans with a Medical Exception
Thousands of K-12 students returning to school this fall will face a cell phone use ban during instructional hours. Diabetes monitoring deserves an exception.